XERIS PHARMACEUTICALS INC (XERS) [Rocket]

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	37.6	19.5	45.7	42.0
Short-term investments	96.2	56.0	66.9
Accounts receivable, net	6.9	4.7		1.2
Inventories	8.4	2.2
Other current assets	3.2	5.1	5.3	0.8
Total current assets	152.2	87.5	117.9	44.1
Property, plant, and equipment, net	6.7	7.9	2.0	0.8
Long-term investments		13.2
Other fixed assets	0.2	0.4	0.1	0.2
Total assets	159.2	109.0	120.0	45.0

Accounts payable	3.1	5.6	0.9	2.0
Accrued expenses	23.9	24.9	8.2	2.6
Short-term debt	0.0	0.0	0.0	0.0
Other current liabilities	1.2	-3.2	1.1	0.3
Total current liabilities	28.2	27.3	10.2	4.9
Long-term debt	87.0	58.3	31.9
Other liabilities	10.2	8.9	2.6	0.1
Total liabilities	125.4	94.6	44.6	5.0

Shareholders' equity [+]	33.8	14.4	75.4	40.0
Paid-in capital	371.1	260.6	196.1	2.8
Retained earnings	-337.4	-246.2	-120.7	-60.6
Tangible shareholders' equity	33.8	14.4	75.4	40.0